L. E. Abrey

686 total citations
6 papers, 466 citations indexed

About

L. E. Abrey is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, L. E. Abrey has authored 6 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Neurology. Recurrent topics in L. E. Abrey's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers) and Neuroblastoma Research and Treatments (2 papers). L. E. Abrey is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers) and Neuroblastoma Research and Treatments (2 papers). L. E. Abrey collaborates with scholars based in United States and Canada. L. E. Abrey's co-authors include Jeffrey J. Raizer, W.K. Alfred Yung, Raja B. Khan, Mark G. Malkin, Timothy F. Cloughesy, Andrew B. Lassman, Janet Dancey, Kathleen R. Lamborn, Minesh P. Mehta and Mark R. Gilbert and has published in prestigious journals such as Journal of Clinical Oncology, Neuro-Oncology and Journal of Neuro-Oncology.

In The Last Decade

L. E. Abrey

6 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. E. Abrey United States	6	386	169	144	108	106	6	466
Scott Peak United States	7	438 1.1×	281 1.7×	131 0.9×	209 1.9×	135 1.3×	9	640
Richard Zuniga United States	6	360 0.9×	211 1.2×	121 0.8×	89 0.8×	141 1.3×	16	498
Sigmund Hsu United States	9	318 0.8×	160 0.9×	160 1.1×	116 1.1×	88 0.8×	26	498
Roy Torcuator United States	8	451 1.2×	233 1.4×	114 0.8×	84 0.8×	132 1.2×	8	585
Kirsten Grunnet Denmark	14	494 1.3×	179 1.1×	151 1.0×	76 0.7×	166 1.6×	25	588
Praveen Medabalmi United States	6	245 0.6×	76 0.4×	113 0.8×	37 0.3×	106 1.0×	10	394
Giovanna Cavallo Italy	11	367 1.0×	233 1.4×	152 1.1×	148 1.4×	105 1.0×	19	565
Toshihide Tsuzuki Japan	7	179 0.5×	112 0.7×	132 0.9×	97 0.9×	68 0.6×	17	352
Despina Misailidou Greece	8	278 0.7×	183 1.1×	92 0.6×	65 0.6×	75 0.7×	9	417
Francesca Vastola Italy	9	421 1.1×	238 1.4×	109 0.8×	52 0.5×	71 0.7×	14	491

Countries citing papers authored by L. E. Abrey

Since Specialization

Citations

This map shows the geographic impact of L. E. Abrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. Abrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. Abrey more than expected).

Fields of papers citing papers by L. E. Abrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. Abrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. Abrey. The network helps show where L. E. Abrey may publish in the future.

Co-authorship network of co-authors of L. E. Abrey

This figure shows the co-authorship network connecting the top 25 collaborators of L. E. Abrey. A scholar is included among the top collaborators of L. E. Abrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. E. Abrey. L. E. Abrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wefel, J.S., Timothy F. Cloughesy, James L. Zazzali, et al.. (2011). Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology. 13(6). 660–668. 76 indexed citations

2.

Raizer, Jeffery J., L. E. Abrey, Andrew B. Lassman, et al.. (2009). A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncology. 12(1). 95–103. 221 indexed citations

3.

Raizer, Jeffrey J., L. E. Abrey, Andrew B. Lassman, et al.. (2009). A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro-Oncology. 12(1). 87–94. 45 indexed citations

4.

Wen, Patrick Y., et al.. (2009). Phase I/II study of sorafenib and temsirolimus for patients with recurrent glioblastoma (GBM) (NABTC 05–02). Journal of Clinical Oncology. 27(15_suppl). 2006–2006. 17 indexed citations

5.

Khan, Raja B., et al.. (2002). A phase II study of extended low-dose temozolomide in recurrent malignant gliomas. Neuro-Oncology. 4(1). 39–43. 91 indexed citations

6.

Abrey, L. E., Marc K. Rosenblum, Esperanza B. Papadopoulos, Barrett H. Childs, & Jonathan L. Finlay. (1999). High Dose Chemotherapy with Autologous Stem Cell Rescue in Adults with Malignant Primary Brain Tumors. Journal of Neuro-Oncology. 44(2). 147–153. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact